Repeated sauna therapy reduces urinary 8-epi-prostaglnadin F2α

Japanese Heart Journal

Volumn 45, Issue 2, 2004, Pages 297-303

  Masuda, Akinori ^a   Miyata, Masaaki ^a   Kihara, Takashi ^a   Minagoe, Shinichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Blood pressure; Coronary risk factors; Nitric oxide (NO); Oxidative stress; Shear stress; Urinary 8 rpi prostaglandin F2

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAUNA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; BODY MASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART RATE; HEMATOCRIT; MIDDLE AGED; PHYSIOLOGY; URINE; VASCULAR ENDOTHELIUM;

ADULT; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS; DINOPROST; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HEMATOCRIT; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RISK FACTORS; STEAM BATH;

EID: 2442672020     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.45.297     Document Type: Article

References (22)

1. Minuz P, Patrignani P, Gaino S, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002; 106: 2800-5.
2. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolaemia. Circulation 1998; 98: 2822-8.
3. 2α and platelet activation in diabetes mellitus. Circulation 1999; 99: 224-9.
4. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198-203.
5. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-70.
6. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997; 17: 2309-15.
7. Imamura M, Biro S, Kihara T, et al. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 2001; 38: 1083-8.
8. Ikeda Y, Biro S, Kamogawa Y, et al. Repeated thermal therapy upregulates arterial endothelial nitric oxide synthase expression in Syrian golden hamsters. Jpn Circ J 2001; 65: 434-8.
9. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997; 95: 2492-9.
10. 2α excretion in man. J Pharmacol Exp Ther 1995; 275: 94-100.
11. Tei C, Horikiri Y, Park JC, et al. Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation 1995; 91: 2582-90.
12. Tei C. Thermal therapy for congestive heart failure: estimation by Tei index. J Cardiol 2001; 37: 155-9.
13. Siewert C, Siewert H, Winterfeld HJ, Strangfeld D. Changes of central and peripheral hemodynamics during isometric and dynamic exercise in hypertensive patients before and after regular sauna therapy. Z Kardiol 1994; 83: 652-7.
14. Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 754-9.
15. Ruef J, Peter K, Nordt TK, Runge MS, Kubler W, Bode C. Oxidative stress and atherosclerosis; its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 1999; 82: 32-7.
16. Misonou H, Morishima-Kawashima M, Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (A beta) in human neuroblastoma cells. Biochemistry 2000; 39: 6951-9.
17. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 1996; 347: 781-6.
18. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342: 145-53.
19. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
20. 2α, in experimental hypercholesterolemia. Cardiovasc Res 1999; 44: 601-7.
21. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002; 106: 2530-2.
22. Takeshita S, Inoue N, Ueyama T, Kawashima S, Yokoyama M. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun 2000; 273: 66-71.